PainChek hits over four-month high on expanded Sabra agreement uptake

By Reuters News

** Shares of Australia's PainChek PCK.AX gains as much as 41.4% to A$0.140, their highest since June 4

** Stock logged its biggest intraday gain since April 14

** Medtech firm says expanded commercial uptake under its master services agreement with Sabra Health Care REIT SBRA.O

** Adds expansion expands its Sabra footprint to 23 US communities across five operators

** Around 1.1 mln shares change hands, nearly 9.7x 30-day average

** PCK down 63.8% YTD

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.